Canakinumab
Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody that inhibits human and chorioallantoic monkey IL-1β with IC50 values of 43.6 and 40.8 pM, respectively. It exhibits anti-inflammatory activity by neutralizing IL-1β signaling, and it has been used for the treatment of gout and coronary artery disease.
Product Specifications
CAS Number
914613-48-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7241028-01 48 Well
Canine Mediator of RNA polymerase II transcription subunit 28 (MED28) ELISA Kit
Ask
View Details 
MBS7241028-02 96 Well
Canine Mediator of RNA polymerase II transcription subunit 28 (MED28) ELISA Kit
Ask
View Details